IPO, OpenAI
Digest more
Navan priced its IPO at $25 per share, aiming to raise around $700 million, with shares set to begin trading on Nasdaq. The company has grown through both organic expansion and strategic acquisitions, and plans to continue acquiring companies post-IPO.
Navan finished its first day trading at an approximate valuation of $4.7 billion, which is about half of its last private valuation of $9.2 billion.
The IPO preparations follow a restructuring of OpenAI completed on October 28 that reduced the company’s reliance on Microsoft, which has committed to investments of $13 billion and now owns about 27 percent of the company. OpenAI was most recently valued around $500 billion in private markets.
Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 to $17 per share. | Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price between $15 and $17 per share.
Medline disclosed on Tuesday that its revenue rose 9.7% in the first half of 2025, as one of the world's largest makers of medical supplies made its IPO filing public ahead of its highly anticipated U.
Medline Inc. eyes a $5B IPO to reduce debt amid strong growth in the medical disposables market. Click here to read my latest analysis of MDLN stock.
Navan, Inc (NASDAQ: NAVN) IPO will take place October, 30 on the NASDAQ exchange under the ticker NAVN. The company is offering shares at an expected price between $24.00 and $26.00 per share with an insider lock-up period of 180 days ending on April 28, 2026.
British lender Shawbrook is set to float on the London Stock Exchange on Thursday at a valuation of about 1.92 billion pounds ($2.58 billion) after pricing its shares at 3.70 pounds each, in what will be London's biggest initial public offering in two years.
OpenAI has been laying the groundwork for an initial public offering (IPO) of up to $1 trillion, according to a Reuters report. This could be one of the biggest IPOs of all time.
Lenskart Solutions IPO is set to be launched on Friday, October 31, 2025 as co-founder and CEO of the eyewear retailer Peyush Bansal is eyeing the 'billionaire' tag for himself.
Feedback